£85.29

Multiple Myeloma - a New Era of Treatment Strategies

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

New to our records — first sighting 13 days ago. We'll learn its rhythm.

13 days of data · current price £85

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 5 days • 5 data points (No recent data available)

Historical
Generating forecast...
£85.29 £81.03 £82.73 £84.44 £86.14 £87.85 £89.55 04 June 2026 05 June 2026 06 June 2026 07 June 2026 08 June 2026

Price Distribution

Price distribution over 5 days • 1 price levels

Days at Price
5 days 0 1 3 4 5 £85 Days at Price

Price Analysis

Most common price: £85 (5 days, 100.0%)

Price range: £85 - £85

Price levels: 1 different prices over 5 days

Description

Multiple Myeloma (MM), the second most common blood cancer in adults, is a clonal plasma cell malignancy within the bone marrow characterized by osteolytic bone lesions, renal disease, and immunodeficiency. It is now well established that MM cell- induced disruption of the bone marrow homeostasis between the highly organized cellular and extracellular compartments supports MM cell proliferation, survival, migration, and drug resistance via activation of various signaling pathways. Based on this knowledge, the prototypic drugs thalidomide, bortezomib, and lenalidomide, which target both MM cells and the bone marrow microenvironment, have already fundamentally changed treatment options of this disease. Indeed, their benefit is now not only shown in relapsed and refractory disease but they also improve overall response, duration of response, and progression-free and overall survival when used as part of first-line regimens. However, despite new insights into MM pathogenesis and exciting derived therapeutic advances, MM still remains incurable. Ongoing studies are therefore aiming to further delineate mechanisms of MM pathogenesis within the bone marrow to identify novel agents with enhanced cytotoxicity and decreased drug resistance to improve patient outcome. Multiple Myeloma - A New Era of Treatment Strategies is devoted to contributions from eminent scientists providing readers with comprehensive accounts of the most recent developments in the field of MM research. It addresses the interests of scientists and clinical investigators in MM research as well as other fields of oncology, in which the microenvironment is believed to play an important role.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
31 January 2018
Listed Since
23 February 2018

Barcode

No barcode data available

Similar Products You Might Like

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science
85% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Springer

£107.98 01 Jun 2026
Multiple Myeloma: Diagnosis and Treatment
84% match

Multiple Myeloma: Diagnosis and Treatment

Springer

£74.05 06 Jun 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
82% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.64 25 May 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research
82% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research

Springer

£107.98 31 May 2026
Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
80% match

Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia

£60.00 12 Jun 2026
Diagnosis of Blood and Bone Marrow Disorders
80% match

Diagnosis of Blood and Bone Marrow Disorders

Springer

£65.49 14 May 2026
Diagnosis of Blood and Bone Marrow Disorders
80% match

Diagnosis of Blood and Bone Marrow Disorders

Springer

£89.12 21 May 2026
Biologic Therapy of Leukemia (Contemporary Hematology)
80% match

Biologic Therapy of Leukemia (Contemporary Hematology)

Humana

£73.10 15 Jun 2026
Chronic Myeloproliferative Disorders
80% match

Chronic Myeloproliferative Disorders

CRC Press

£120.00 31 May 2026
Chronic Myeloid Leukemia (Hematologic Malignancies)
80% match

Chronic Myeloid Leukemia (Hematologic Malignancies)

Springer

£88.17 30 May 2026
The Myelodysplastic Syndromes
80% match

The Myelodysplastic Syndromes

Springer

£120.00 19 May 2026
Handbook of Leukemia
79% match

Handbook of Leukemia

Hayle Medical

£77.26 31 May 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
79% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.70 27 May 2026
Bone Metastases: A translational and Clinical Approach: 21 (Cancer Metastasis - Biology and Treatment, 21)
79% match

Bone Metastases: A translational and Clinical Approach: 21 (Cancer Metastasis - Biology and Treatment, 21)

Springer

£108.92 24 May 2026
Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies (Advances in Blood Disorders, 2)
79% match

Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies (Advances in Blood Disorders, 2)

Routledge

£87.05 25 May 2026
HIV-associated Hematological Malignancies
79% match

HIV-associated Hematological Malignancies

Springer

£103.24 02 Jun 2026
Molecular Targets and Strategies in Cancer Prevention
79% match

Molecular Targets and Strategies in Cancer Prevention

Springer

£107.33 25 May 2026
Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML
78% match

Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML

CREATESPACE

£45.98 24 May 2026
Aplastic Anemia and Other Bone Marrow Failure Syndromes
78% match

Aplastic Anemia and Other Bone Marrow Failure Syndromes

Springer

£77.14 25 May 2026
Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies
78% match

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies

Springer

£84.24 26 May 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
78% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£107.98 11 Jun 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
78% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 01 Jun 2026
Adult T-cell Leukemia/Lymphoma
78% match

Adult T-cell Leukemia/Lymphoma

Springer

£99.03 06 Jun 2026
Radiological Imaging in Hematological Malignancies (Medical Radiology / Diagnostic Imaging)
78% match

Radiological Imaging in Hematological Malignancies (Medical Radiology / Diagnostic Imaging)

Springer

£67.00 14 May 2026